324 related articles for article (PubMed ID: 10214357)
1. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
2. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
3. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10.
Asirvatham JR; Pai R; Chacko G; Nehru AG; John J; Chacko AG; Muliyil J
Neurol India; 2013; 61(2):138-43. PubMed ID: 23644312
[TBL] [Abstract][Full Text] [Related]
7. Association of loss of 1p and alterations of chromosome 14 in meningioma progression.
Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Callaghan R; Collado M; Roldan P; Llombart-Bosch A
Cancer Genet Cytogenet; 2004 Jan; 148(2):123-8. PubMed ID: 14734222
[TBL] [Abstract][Full Text] [Related]
8. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of allelic losses and telomerase activity in meningiomas.
Leuraud P; Dezamis E; Aguirre-Cruz L; Taillibert S; Lejeune J; Robin E; Mokhtari K; Boch AL; Cornu P; Delattre JY; Sanson M
J Neurosurg; 2004 Feb; 100(2):303-9. PubMed ID: 15098535
[TBL] [Abstract][Full Text] [Related]
13. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression.
Murakami M; Hashimoto N; Takahashi Y; Hosokawa Y; Inazawa J; Mineura K
Cancer Genet Cytogenet; 2003 Jan; 140(2):99-106. PubMed ID: 12645646
[TBL] [Abstract][Full Text] [Related]
14. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes with prognostic value in histologically benign meningiomas.
Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression.
Lindblom A; Ruttledge M; Collins VP; Nordenskjöld M; Dumanski JP
Int J Cancer; 1994 Feb; 56(3):354-7. PubMed ID: 8314321
[TBL] [Abstract][Full Text] [Related]
18. Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.
Baser ME; Poussaint TY
J Med Genet; 2006 Mar; 43(3):285-7. PubMed ID: 15980114
[TBL] [Abstract][Full Text] [Related]
19. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
[TBL] [Abstract][Full Text] [Related]
20. Recurrence-associated chromosomal anomalies in meningiomas: Single-institution study and a systematic review with meta-analysis.
Och W; Szmuda T; Sikorska B; Springer J; Jaskólski D; Zakrzewska M; Liberski PP
Neurol Neurochir Pol; 2016; 50(6):439-448. PubMed ID: 27575681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
